However, it has not been reported in prostate cancer bone metastasis patients.[12] Understanding the mechanisms of the AMPK/Beclin-1 pathway and its role in regulating cellular autophagy could reduce the severity and progression of prostate cancer bone metastasis, leading to improved treatment strategies. Here, BECN1 is linked to Familial prostate cancer.